Both in Pharmaceuticals
TransCode Therapeutics vs Aardvark Therapeutics
Over the past year RNAZ returned −86.3% and AARD returned −87.4%; their daily moves had a correlation of -0.01.
RNAZ −86.3% AARD −87.4%Growth of $1, one year, split-adjusted
| Metric | RNAZ | AARD |
|---|---|---|
| Price | $1.74 | $1.51 |
| Market cap | $29.5M | $33.0M |
| Today | +4.19% | +16.15% |
| 1 month | +6.7% | −71.8% |
| 6 months | −79.3% | −71.0% |
| Year to date | −74.5% | −88.5% |
| 1 year | — | −87.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | $73.9M |
| Dividend yield | — | — |
| Volatility (60d) | 76.2% | 241.1% |
| Short % of float | 8.1% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).